AI-generated summary
The authors studied photobiomodulation as a treatment for glioblastoma in 6-month-old and 24-month-old rats with a fluorescent tumor model. They report that the treatment increased survival in younger rats but not in older rats, which they associate with improved meningeal lymphatic function and immune cell traffic. The study used animals rather than people.
- Who or what was studied
- 6-month-old and 24-month-old rats with a fluorescent glioblastoma model
- Limits stated in the abstract
- The abstract describes an animal study, so the findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on discovmed.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.